Patent · US Expired

Chimeric antibody with specificity to human B cell surface antigen

US6652852B1 · kind B1 · utility

61Cited by

23References

30Claims

0Family size

Assignee

Royalty Pharma Finance Trust · US

Inventors

Randy R. Robinson · Walnut Creek, US
Alvin Y. Liu · Oceanside, US
Jeffrey A. Ledbetter · Shoreline, US

Key dates

Filing date	Nov 28, 2000
Grant date	Nov 25, 2003
Priority date	—
Expiry date	Nov 28, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A chimeric antibody with human constant region and murine variable region, having specificity to a 35 kDA polypeptide (Bp35(CD20)) expressed on the surface of human B cells, methods of production, and uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.